Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?

2010/03/30 by Jesper Grau Eriksen, P. Lassen, Pernille Lassen +1 · 2 citations
Medicine · #Cancer Diagnosis and Treatment #Head and Neck Cancer Studies #Head and Neck Surgical Oncology

paper · doi:10.1016/s1470-2045(10)70035-8

openalex publication_date 2010/03/30 · crossref created 2010/03/30 · crossref issued 2010/04/01 · crossref published 2010/04/01 · crossref published-print 2010/04/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/26 · crossref indexed 2026/04/28 · openalex updated_date 2026/08/01

Citations

• Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

Cited by

• The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome
• HPV-positive oropharyngeal cancer [wikipedia]